Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BioLine Rx Q2 EPS $(0.01) Beats $(0.15) Estimate

BioLine Rx (NASDAQ:BLRX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.15) by 93.33 percent. This is a 66.67 percent increase over losses of $(0.03) per share from the

byBill Haddad

August 18, 2021

1 minute read

BioLine Rx (NASDAQ:BLRX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.15) by 93.33 percent. This is a 66.67 percent increase over losses of $(0.03) per share from the same period last year.